Affinity Data by Patent

Patent code US9278093

Found 8 hits of Enzyme Inhibition Constant Data
Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	k_off s^-1	k_on M^-1s^-1	pH	Temp °C
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM50078618 (CHEMBL3415173 \| US9278093, 2) Show SMILES Cc1nnc2CCc3cc(cc(F)c3-n12)-c1cncc(F)c1C Show InChI	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	n/a	37
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					Assay Description Compounds of the Examples 1 to 3 were assayed for V79-Human-CYP11B2 and V79-Human-CYP11B1 by modifying the protocol described in J. Steroid Biochem. ...				US Patent US9278093 (2016) BindingDB Entry DOI: 10.7270/Q2HT2N5D
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM212442 (US9278093, 1) Show SMILES Show InChI	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7.30	n/a	n/a	n/a	n/a	n/a	37
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					Assay Description Compounds of the Examples 1 to 3 were assayed for V79-Human-CYP11B2 and V79-Human-CYP11B1 by modifying the protocol described in J. Steroid Biochem. ...				US Patent US9278093 (2016) BindingDB Entry DOI: 10.7270/Q2HT2N5D
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM212443 (US9278093, 3) Show SMILES Show InChI	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	9.5	n/a	n/a	n/a	n/a	n/a	37
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					Assay Description Compounds of the Examples 1 to 3 were assayed for V79-Human-CYP11B2 and V79-Human-CYP11B1 by modifying the protocol described in J. Steroid Biochem. ...				US Patent US9278093 (2016) BindingDB Entry DOI: 10.7270/Q2HT2N5D
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM212444 (US9278093, 4) Show SMILES Show InChI	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	21.6	n/a	n/a	n/a	n/a	n/a	37
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					Assay Description Compounds of the Examples 1 to 3 were assayed for V79-Human-CYP11B2 and V79-Human-CYP11B1 by modifying the protocol described in J. Steroid Biochem. ...				US Patent US9278093 (2016) BindingDB Entry DOI: 10.7270/Q2HT2N5D
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					More data for this Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial (Homo sapiens (Human))	BDBM50078618 (CHEMBL3415173 \| US9278093, 2) Show SMILES Cc1nnc2CCc3cc(cc(F)c3-n12)-c1cncc(F)c1C Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.42E+3	n/a	n/a	n/a	n/a	n/a	37
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					Assay Description Compounds of the Examples 1 to 3 were assayed for V79-Human-CYP11B2 and V79-Human-CYP11B1 by modifying the protocol described in J. Steroid Biochem. ...				US Patent US9278093 (2016) BindingDB Entry DOI: 10.7270/Q2HT2N5D
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					More data for this Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial (Homo sapiens (Human))	BDBM212442 (US9278093, 1) Show SMILES Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.29E+3	n/a	n/a	n/a	n/a	n/a	37
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					Assay Description Compounds of the Examples 1 to 3 were assayed for V79-Human-CYP11B2 and V79-Human-CYP11B1 by modifying the protocol described in J. Steroid Biochem. ...				US Patent US9278093 (2016) BindingDB Entry DOI: 10.7270/Q2HT2N5D
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					More data for this Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial (Homo sapiens (Human))	BDBM212443 (US9278093, 3) Show SMILES Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.97E+3	n/a	n/a	n/a	n/a	n/a	37
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					Assay Description Compounds of the Examples 1 to 3 were assayed for V79-Human-CYP11B2 and V79-Human-CYP11B1 by modifying the protocol described in J. Steroid Biochem. ...				US Patent US9278093 (2016) BindingDB Entry DOI: 10.7270/Q2HT2N5D
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					More data for this Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial (Homo sapiens (Human))	BDBM212444 (US9278093, 4) Show SMILES Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	9.80E+3	n/a	n/a	n/a	n/a	n/a	37
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					Assay Description Compounds of the Examples 1 to 3 were assayed for V79-Human-CYP11B2 and V79-Human-CYP11B1 by modifying the protocol described in J. Steroid Biochem. ...				US Patent US9278093 (2016) BindingDB Entry DOI: 10.7270/Q2HT2N5D
Merck Sharp & Dohme Corp.; ElexoPharm GmbH US Patent					More data for this Ligand-Target Pair

Reorder this table by EC50
Reorder this table by IC50
Reorder this table by Kd
Reorder this table by KON
Reorder this table by KOFF
Reorder this table by pH
Reorder this table by T
Reorder this table by ΔH°
Reorder this table by -TΔS°
Change energy units to:kcal/mole

* indicates data uncertainty>20%